Krensavage Asset Management LLC
Krensavage Asset Management LLC latest Q1_2021 13F filings reported $288,899,000 in market value on this 2021-05-18 report date . The portfolio quarterly return is -15.63%. This fund has 12 securities concentrations of 100% weights.
Krensavage Asset Management LLC largest holding is Enanta Pharmaceuticals Inc. with weight of 14.73% and $42,556,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.
Portfolio Performance History
| FILE DATE | REPORT PERIOD | QTR YEAR | FILE TYPE | NOS. OF STOCKS | REPORTED VALUE | RETURN |
|---|---|---|---|---|---|---|
| 2021-05-18 | 2021-03-31 | Q1_2021 | 13F-HR | 12 | $288,899,000 | -15.63% |
| 2021-02-16 | 2020-12-31 | Q4_2020 | 13F-HR | 12 | $342,426,000 | 9.02% |
| 2020-12-08 | 2020-09-30 | Q3_2020 | 13F-HR/A | 11 | $314,096,000 | 0.00% |
| 2020-11-17 | 2020-09-30 | Q3_2020 | 13F-HR | 11 | $314,096,000 | -14.55% |
| 2020-08-20 | 2020-06-30 | Q2_2020 | 13F-HR/A | 11 | $367,575,000 | 0.00% |
| 2020-08-17 | 2020-06-30 | Q2_2020 | 13F-HR | 11 | $367,575,000 | 18.23% |
| 2020-05-18 | 2020-03-31 | Q1_2020 | 13F-HR | 13 | $310,898,000 | 6.09% |
| 2020-02-18 | 2019-12-31 | Q4_2019 | 13F-HR | 12 | $293,048,000 | 12.52% |
| 2019-11-15 | 2019-09-30 | Q3_2019 | 13F-HR | 10 | $260,445,000 | -15.47% |
| 2019-08-14 | 2019-06-30 | Q2_2019 | 13F-HR | 10 | $308,111,000 | -16.74% |
| 2019-05-15 | 2019-03-31 | Q1_2019 | 13F-HR | 12 | $370,055,000 | 24.95% |
| 2019-02-15 | 2018-12-31 | Q4_2018 | 13F-HR/A | 13 | $296,165,000 | 0.00% |
| 2019-02-14 | 2018-12-31 | Q4_2018 | 13F-HR | 12 | $294,927,000 | -24.21% |
| 2018-11-14 | 2018-09-30 | Q3_2018 | 13F-HR | 14 | $389,139,000 | -0.63% |
| 2018-08-13 | 2018-06-30 | Q2_2018 | 13F-HR | 14 | $391,605,000 | -5.00% |
| 2018-05-14 | 2018-03-31 | Q1_2018 | 13F-HR | 16 | $412,201,000 | 28.48% |
| 2018-02-14 | 2017-12-31 | Q4_2017 | 13F-HR | 16 | $320,818,000 | 0.00% |
| 2017-11-14 | 2017-09-30 | Q3_2017 | 13F-HR | 14 | $320,803,000 | -2.61% |
| 2017-08-14 | 2017-06-30 | Q2_2017 | 13F-HR | 15 | $329,397,000 | 6.22% |
| 2017-05-15 | 2017-03-31 | Q1_2017 | 13F-HR | 15 | $310,101,000 | 11.18% |
| 2017-02-13 | 2016-12-31 | Q4_2016 | 13F-HR | 16 | $278,919,000 | 0.79% |
| 2016-11-14 | 2016-09-30 | Q3_2016 | 13F-HR | 17 | $276,731,000 | -0.29% |
| 2016-08-12 | 2016-06-30 | Q2_2016 | 13F-HR | 20 | $277,542,000 | -0.42% |